206 related articles for article (PubMed ID: 15561879)
1. A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation.
Carter G; Young LS; Bermudez LE
Antimicrob Agents Chemother; 2004 Dec; 48(12):4907-10. PubMed ID: 15561879
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan.
Kohno Y; Ohno H; Miyazaki Y; Higashiyama Y; Yanagihara K; Hirakata Y; Fukushima K; Kohno S
Antimicrob Agents Chemother; 2007 Nov; 51(11):4071-6. PubMed ID: 17709469
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare.
Steele-Moore L; Stark K; Holloway WJ
Antimicrob Agents Chemother; 1999 Jun; 43(6):1530. PubMed ID: 10383373
[No Abstract] [Full Text] [Related]
4. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
[TBL] [Abstract][Full Text] [Related]
5. Clarithromycin prophylaxis against disseminated Mycobacterium avium complex in patients with AIDS.
Archange YR; Carrey Z; Zanlungo PG
J Int Assoc Physicians AIDS Care; 1995 Aug; 1(7):20-2. PubMed ID: 11362747
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium.
Deshpande D; Gumbo T
Future Microbiol; 2011 Apr; 6(4):433-9. PubMed ID: 21526944
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
Huang CC; Wu MF; Chen HC; Huang WC
J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium avium strains resistant to clarithromycin and azithromycin.
Heifets L; Mor N; Vanderkolk J
Antimicrob Agents Chemother; 1993 Nov; 37(11):2364-70. PubMed ID: 8031351
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium avium strains resistant to clarithromycin and azithromycin.
Wolinsky E
Antimicrob Agents Chemother; 1994 Mar; 38(3):635. PubMed ID: 8031406
[No Abstract] [Full Text] [Related]
10. In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment?
Yajko DM
Res Microbiol; 1992 May; 143(4):411-9. PubMed ID: 1455069
[No Abstract] [Full Text] [Related]
11. [Azithromycin and Mycobacterium avium infection].
Perronne C
Pathol Biol (Paris); 1995 Jun; 43(6):565-7. PubMed ID: 8539084
[TBL] [Abstract][Full Text] [Related]
12. Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin.
Doucet-Populaire F; Truffot-Pernot C; Grosset J; Jarlier V
J Antimicrob Chemother; 1995 Jul; 36(1):129-36. PubMed ID: 8537260
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.
Matsiota-Bernard P; Zinzendorf N; Onody C; Guenounou M
J Infect; 2000 Jan; 40(1):49-54. PubMed ID: 10762111
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility testing of Mycobacterium avium complex isolates.
Heifets L
Antimicrob Agents Chemother; 1996 Aug; 40(8):1759-67. PubMed ID: 8843278
[No Abstract] [Full Text] [Related]
16. In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex.
Gevaudan MJ; Bollet C; Mallet MN; de Micco P
J Antimicrob Chemother; 1993 May; 31(5):725-30. PubMed ID: 8392998
[TBL] [Abstract][Full Text] [Related]
17. Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection.
Deshpande D; Srivastava S; Meek C; Leff R; Hall GS; Gumbo T
Antimicrob Agents Chemother; 2010 Jun; 54(6):2534-9. PubMed ID: 20385862
[TBL] [Abstract][Full Text] [Related]
18. Postantibiotic effect of clarithromycin alone and combined with ethambutol against Mycobacterium avium complex.
Ellis LC; Benson CA; Koenig GI; Trenholme GM
Antimicrob Agents Chemother; 1995 Dec; 39(12):2803-6. PubMed ID: 8593025
[TBL] [Abstract][Full Text] [Related]
19. Bacteriostatic and bactericidal activities of gentamicin alone and in combination with clarithromycin against Mycobacterium avium.
Heifets LB; Lindholm-Levy PJ; Comstock RD
Antimicrob Agents Chemother; 1992 Aug; 36(8):1695-8. PubMed ID: 1416852
[TBL] [Abstract][Full Text] [Related]
20. Minimum inhibitory concentrations of azithromycin in clinical isolates of
Uwamino Y; Aoki W; Inose R; Kamoshita Y; Mikita K; Namkoong H; Nishimura T; Matsushita H; Hasegawa N
Microbiol Spectr; 2024 Jun; 12(6):e0021824. PubMed ID: 38687080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
